Skip to main content
. 2016 Apr 11;25(13):1448–1455. doi: 10.1177/0961203316642309

Table 2.

Belimumab pharmacokinetic estimates for the full SC population pharmacokinetic model

Parameter Model estimates (%RSE)
CL (mL/day) 208 (3.9)
Vss (mL) 5250 (NA)
ka (day−1) 0.312 (6.6)
Lag time (day) 0.177 (3.4)
F 0.761 (4.6)

%RSE: percentage relative standard error, calculated as (standard error/mean) × 100%; Vss: volume of distribution at steady-state; NA: not applicable; ka: first-order absorption rate constant; F: bioavailability.